{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:52Z","timestamp":1790775772634,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501207"],"award-info":[{"award-number":["81501207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271928"],"award-info":[{"award-number":["81271928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501207"],"award-info":[{"award-number":["81501207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271928"],"award-info":[{"award-number":["81271928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prolyl isomerase Pin1 is widely over-expressed or over-activated in cancers and promotes tumorigenesis. The authors investigated the expression level of Pin1 and analyzed the prognostic value of Pin1 expression using a large-scale melanoma tissue microarray study. Two independent sets of tissue microarrays were employed, including 114 melanoma cases in the discovery set and 424 in the validation set (538 cases in total), 32 normal nevi and 86 dysplastic nevi 118 cases of nevi. The subcellular Pin1 expression in different stages of melanocytic lesions and its prognostic significance were studied. High expression (IRS 0\u20138) of cytoplasmic Pin1 was observed in 3.13%, 8.33%, 16.49% and 22.76% of the biopsies in normal nevi, dysplastic nevi, primary melanoma and metastatic melanoma, respectively. Significant differences for cytoplasmic Pin1 staining were observed between normal nevi and metastatic melanoma (<jats:italic>P<\/jats:italic>\u2009=\u20090.011, \u03c7<jats:sup>2<\/jats:sup> test), between dysplastic nevi and primary melanoma (<jats:italic>P<\/jats:italic>\u2009=\u20090.046, \u03c7<jats:sup>2<\/jats:sup> test) and between dysplastic nevi and metastatic melanoma (<jats:italic>P<\/jats:italic>\u2009=\u20090.016, \u03c7<jats:sup>2<\/jats:sup> test). Kaplan-Meier survival analysis showed that increased cytoplasmic Pin1 expression was associated with a worse 5-year melanoma-specific survival of melanoma (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and metastatic melanoma patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.004). Multivariate Cox regression analysis showed that cytoplasmic Pin1 expression is an independent prognostic factor in melanoma. Our data indicate that cytoplasmic Pin1 plays an important role in melanoma pathogenesis and progression, and serve as a potential prognostic marker for melanoma.<\/jats:p>","DOI":"10.1038\/s41598-018-34906-6","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T12:43:24Z","timestamp":1541767404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Martinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"34906_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrm2261","volume":"8","author":"KP Lu","year":"2007","unstructured":"Lu, K. P. & Zhou, X. Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8, 904\u2013916 (2007).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"34906_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tibs.2011.07.001","volume":"36","author":"YC Liou","year":"2011","unstructured":"Liou, Y. C., Zhou, X. Z. & Lu, K. P. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 36, 501\u2013514 (2011).","journal-title":"Trends Biochem Sci"},{"key":"34906_CR3","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1017\/S1462399411001906","volume":"13","author":"TH Lee","year":"2011","unstructured":"Lee, T. H., Pastorino, L. & Lu, K. P. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev Mol Med 13, e21 (2011).","journal-title":"Expert Rev Mol Med"},{"key":"34906_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature14044","volume":"520","author":"J Marsolier","year":"2015","unstructured":"Marsolier, J. et al. Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation. Nature 520, 378\u2013382 (2015).","journal-title":"Nature"},{"key":"34906_CR5","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0002-9440(10)63731-5","volume":"164","author":"L Bao","year":"2004","unstructured":"Bao, L. et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164, 1727\u20131737 (2004).","journal-title":"Am J Pathol"},{"key":"34906_CR6","first-page":"1097","volume":"21","author":"KW Leung","year":"2009","unstructured":"Leung, K. W. et al. Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma. Oncol Rep 21, 1097\u20131104 (2009).","journal-title":"Oncol Rep"},{"key":"34906_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s12013-014-0274-0","volume":"71","author":"M Shi","year":"2015","unstructured":"Shi, M. et al. Pin1 is overexpressed and correlates with poor prognosis in gastric cancer. Cell Biochem Biophys 71, 857\u2013864 (2015).","journal-title":"Cell Biochem Biophys"},{"key":"34906_CR8","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1128\/MCB.26.4.1463-1479.2006","volume":"26","author":"F Suizu","year":"2006","unstructured":"Suizu, F., Ryo, A., Wulf, G., Lim, J. & Lu, K. P. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol Cell Biol 26, 1463\u20131479 (2006).","journal-title":"Mol Cell Biol"},{"key":"34906_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc.2016.49","volume":"16","author":"XZ Zhou","year":"2016","unstructured":"Zhou, X. Z. & Lu, K. P. The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target. Nat Rev Cancer 16, 463\u2013478 (2016).","journal-title":"Nat Rev Cancer"},{"key":"34906_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1006\/bbrc.1999.1736","volume":"265","author":"F Fujimori","year":"1999","unstructured":"Fujimori, F., Takahashi, K., Uchida, C. & Uchida, T. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun 265, 658\u2013663 (1999).","journal-title":"Biochem Biophys Res Commun"},{"key":"34906_CR11","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1038\/sj.emboj.7600323","volume":"23","author":"G Wulf","year":"2004","unstructured":"Wulf, G., Garg, P., Liou, Y. C., Iglehart, D. & Lu, K. P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 23, 3397\u20133407 (2004).","journal-title":"EMBO J"},{"key":"34906_CR12","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1038\/sj.onc.1210153","volume":"26","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 26, 3835\u20133845 (2007).","journal-title":"Oncogene"},{"key":"34906_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccr.2011.06.004","volume":"20","author":"JE Girardini","year":"2011","unstructured":"Girardini, J. E. et al. A Pin1\/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 20, 79\u201391 (2011).","journal-title":"Cancer Cell"},{"key":"34906_CR14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.18632\/oncotarget.329","volume":"2","author":"M Napoli","year":"2011","unstructured":"Napoli, M., Girardini, J. E., Piazza, S. & Del Sal, G. Wiring the oncogenic circuitry: Pin1 unleashes mutant p53. Oncotarget 2, 654\u2013656 (2011).","journal-title":"Oncotarget"},{"key":"34906_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-7-91","volume":"7","author":"PB Lam","year":"2008","unstructured":"Lam, P. B. et al. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability. Mol Cancer 7, 91 (2008).","journal-title":"Mol Cancer"},{"key":"34906_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tibs.2008.12.004","volume":"34","author":"A Ryo","year":"2009","unstructured":"Ryo, A., Wulf, G., Lee, T. H. & Lu, K. P. Pinning down HER2-ER crosstalk in SMRT regulation. Trends Biochem Sci 34, 162\u2013165 (2009).","journal-title":"Trends Biochem Sci"},{"key":"34906_CR17","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.1158\/0008-5472.CAN-08-0579","volume":"68","author":"Q Ding","year":"2008","unstructured":"Ding, Q. et al. Down-regulation of myeloid cell leukemia-1 through inhibiting Erk\/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res 68, 6109\u20136117 (2008).","journal-title":"Cancer Res"},{"key":"34906_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/cdd.2016.122","volume":"24","author":"A Rustighi","year":"2017","unstructured":"Rustighi, A. et al. PIN1 in breast development and cancer: a clinical perspective. Cell Death Differ 24, 200\u2013211 (2017).","journal-title":"Cell Death Differ"},{"key":"34906_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1535-6108(02)00161-7","volume":"2","author":"AN Houghton","year":"2002","unstructured":"Houghton, A. N. & Polsky, D. Focus on melanoma. Cancer Cell 2, 275\u2013278 (2002).","journal-title":"Cancer Cell"},{"key":"34906_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller, A. J. & Mihm, M. C. Jr. Melanoma. N Engl J Med 355, 51\u201365 (2006).","journal-title":"N Engl J Med"},{"key":"34906_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont, A. M., Spatz, A. & Robert, C. Cutaneous melanoma. Lancet 383, 816\u2013827 (2014).","journal-title":"Lancet"},{"key":"34906_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.mayocp.2014.02.009","volume":"89","author":"AT Slominski","year":"2014","unstructured":"Slominski, A. T. & Carlson, J. A. Melanoma resistance: a bright future for academicians and a challenge for patient advocates. Mayo Clin Proc 89, 429\u2013433 (2014).","journal-title":"Mayo Clin Proc"},{"key":"34906_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4149\/neo_2013_013","volume":"60","author":"J Jin","year":"2013","unstructured":"Jin, J. et al. RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells. Neoplasma 60, 92\u2013100 (2013).","journal-title":"Neoplasma"},{"key":"34906_CR24","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/onc.2015.282","volume":"35","author":"F Kruiswijk","year":"2016","unstructured":"Kruiswijk, F. et al. Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling. Oncogene 35, 2166\u20132177 (2016).","journal-title":"Oncogene"},{"key":"34906_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15772","volume":"8","author":"E Campaner","year":"2017","unstructured":"Campaner, E. et al. A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action. Nat Commun 8, 15772 (2017).","journal-title":"Nat Commun"},{"key":"34906_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ncb1822","volume":"11","author":"A Rustighi","year":"2009","unstructured":"Rustighi, A. et al. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat Cell Biol 11, 133\u2013142 (2009).","journal-title":"Nat Cell Biol"},{"key":"34906_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/emmm.201302909","volume":"6","author":"A Rustighi","year":"2014","unstructured":"Rustighi, A. et al. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO Mol Med 6, 99\u2013119 (2014).","journal-title":"EMBO Mol Med"},{"key":"34906_CR28","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1128\/MCB.22.15.5281-5295.2002","volume":"22","author":"A Ryo","year":"2002","unstructured":"Ryo, A. et al. PIN1 is an E2F target gene essential for Neu\/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 22, 5281\u20135295 (2002).","journal-title":"Mol Cell Biol"},{"key":"34906_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molcel.2011.03.005","volume":"42","author":"TH Lee","year":"2011","unstructured":"Lee, T. H. et al. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. Mol Cell 42, 147\u2013159 (2011).","journal-title":"Mol Cell"},{"key":"34906_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/pcmr.12194","volume":"27","author":"B Bedogni","year":"2014","unstructured":"Bedogni, B. Notch signaling in melanoma: interacting pathways and stromal influences that enhance Notch targeting. Pigment Cell Melanoma Res 27, 162\u2013168 (2014).","journal-title":"Pigment Cell Melanoma Res"},{"key":"34906_CR31","doi-asserted-by":"publisher","first-page":"8149","DOI":"10.1073\/pnas.1200804109","volume":"109","author":"V Rangasamy","year":"2012","unstructured":"Rangasamy, V. et al. Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function. Proc Natl Acad Sci USA 109, 8149\u20138154 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"34906_CR32","doi-asserted-by":"publisher","first-page":"36575","DOI":"10.1074\/jbc.M504548200","volume":"280","author":"F Eckerdt","year":"2005","unstructured":"Eckerdt, F. et al. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J Biol Chem 280, 36575\u201336583 (2005).","journal-title":"J Biol Chem"},{"key":"34906_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11010-012-1322-y","volume":"367","author":"YS Cho","year":"2012","unstructured":"Cho, Y. S. et al. TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2. Mol Cell Biochem 367, 85\u201392 (2012).","journal-title":"Mol Cell Biochem"},{"key":"34906_CR34","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1158\/0008-5472.CAN-12-4360","volume":"73","author":"CH Chen","year":"2013","unstructured":"Chen, C. H. et al. SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function. Cancer Res 73, 3951\u20133962 (2013).","journal-title":"Cancer Res"},{"key":"34906_CR35","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.2353\/ajpath.2010.100377","volume":"177","author":"SM Jafarnejad","year":"2010","unstructured":"Jafarnejad, S. M., Wani, A. A., Martinka, M. & Li, G. Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am J Pathol 177, 2741\u20132752 (2010).","journal-title":"Am J Pathol"},{"key":"34906_CR36","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele, W. & Stegner, H. E. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8, 138\u2013140 (1987).","journal-title":"Pathologe"},{"key":"34906_CR37","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.18632\/oncotarget.9409","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou, J., Cheng, Y., Tang, L., Martinka, M. & Kalia, S. Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells. Oncotarget 8, 18712\u201318725 (2017).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34906-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34906-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34906-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:38:29Z","timestamp":1671622709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34906-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34906"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34906-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16867"}}